-- Robert Preidt
MONDAY, Jan. 17 (HealthDay News) -- Patients at high risk for
melanoma benefit from a follow-up program that can detect the
deadly skin cancer at an early stage, new research finds, while a
second study notes that embarrassment prevents some people from
having a doctor examine their skin for suspicious lesions.
Both studies appear in the journal
Archives of Dermatology.
People at high risk for melanoma, the most deadly form of skin
cancer, include those with fair skin, blond or red hair, blue eyes,
freckles and/or a family history of the disease, as well as those
who have been exposed to artificial UV-A radiation or who have
suffered severe sunburns, especially during childhood.
"Patients who are at high risk, who fit this profile, should be routinely screened [for skin cancer] annually along with other surveillance measures for colon cancer, mammograms, etc.," advised one dermatologist, Dr. Michele Green of Lenox Hill Hospital in New York City. She was not involved in the new research.
The first study, conducted in Spain, included 40 melanoma
patients who were in a special follow-up program designed for
high-risk individuals, as well as 161 melanoma patients who were
simply referred to another clinician in the same hospital. All the
melanoma diagnoses were made using dermoscopy, a noninvasive
microscopic evaluation of a skin lesion.
The researchers found that only 12 percent of melanomas
diagnosed in the follow-up program fulfilled all four criteria for
melanoma detection: asymmetry, uneven borders, colors, and
differential dermoscopic structures, compared with almost 64
percent of melanomas diagnosed in the doctor-referred group.
In addition, 70 percent of melanomas diagnosed in the follow-up
group had not spread beyond the initial site, compared with about
28 percent of those in the referred group. Tumors also tended to be
thinner in the follow-up group.
In the follow-up group, melanomas were diagnosed at the earliest
stages: 70 percent at stage zero and 30 percent at stage IA. In the
referral group, about 28 percent of melanomas were diagnosed at
stage zero, 37.6 percent at stage IA, nearly 13 percent at stage
IB, about 11 percent at stage II, 8.5 percent at stage III, and 2.4
percent at stage IV.
The study was published online Monday but will appear in the
journal's May print edition.
The second study, appearing in the January issue of the journal,
found that patient embarrassment, time constraints and other health
conditions may prevent doctors from conducting regular full-body
skin examinations of their patients.
It also found that dermatologists are much more likely than
internists and family doctors to conduct these screenings for skin
Researchers analyzed survey responses from 679 dermatologists,
559 family practitioners (doctors specializing in family medicine),
and 431 internists from across the United States. The results
showed that regular full-body skin examinations of patients were
conducted by 81.3 percent of dermatologists, compared to only 59.6
percent of family practitioners and 56.4 percent of internists.
The most common reasons for not performing this type of
examination were patient embarrassment/reluctance, time
constraints, and other patient illnesses.
Time constraints were cited by 54.5 percent of internists and
54.4 percent of family practitioners, as compared to only about 31
percent of dermatologists. Patient embarrassment/reluctance was
cited by about 44 percent of dermatologists, nearly 33 percent of
internists and just over 31 percent of family practitioners.
Identifying these barriers can help health providers overcome
them, said a team led by Susan A. Oliveria of Memorial
Sloan-Kettering Cancer Center, New York City.
Green agreed that the full-body skin exam should be a must for
anyone at risk of skin cancer.
"I have one rule in my office.
All new patients need to get undressed and have a full skin
examination. It says it on the paper work that patients read and
sign at the time of the initial consultation," she said.
"These screenings will be incredibly productive and save lives if these subset of patients are screened on a regular basis," Green added.
The U.S. National Cancer Institute has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.